Sarepta’s DMD drug hit with FDA Complete Response Letter
admin 20th August 2019 Uncategorised 0The company say they are “surprised” to have received the letter. More: Sarepta’s DMD drug hit with FDA Complete Response Letter Source: News
read more
The company say they are “surprised” to have received the letter. More: Sarepta’s DMD drug hit with FDA Complete Response Letter Source: News
read moreThe funding comes as part of the government’s commitment to transforming mental health care. More: £3.3m boost for mental illness in children Source: News
read moreForxiga has had a string of successes recently, as it was recommended by NICE and had its EU marketing authorisation updated earlier this month. More: Positive results continue success for Forxiga Source: News
read moreThe drive includes a one-hour identification and treatment ambition, as well as a new ‘alert and action’ technology. More: Nationwide sepsis push saves ‘hundreds of lives’ Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals